Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0001077183-20-000227)

Filing Details

Accession Number:
0001077183-20-000227
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-12-15 20:51:33
Reporting Period:
2020-12-14
Accepted Time:
2020-12-15 20:51:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1077183 Neogenomics Inc NEO Services-Testing Laboratories (8734) 742897368
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1761625 Martin Lawrence Weiss 12701 Commonwealth Drive Suite 9
Fort Myers FL 33913		 Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-12-14 50,000 $6.98 61,717 No 4 M Direct
Common Stock Acquisiton 2020-12-14 20,000 $7.27 81,717 No 4 M Direct
Common Stock Acquisiton 2020-12-14 13,333 $9.22 95,050 No 4 M Direct
Common Stock Acquisiton 2020-12-14 16,666 $13.87 111,716 No 4 M Direct
Common Stock Acquisiton 2020-12-14 9,005 $19.60 120,721 No 4 M Direct
Common Stock Disposition 2020-12-14 20,200 $51.06 100,521 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Show Other Fields >>
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2020-12-14 50,000 $0.00 50,000 $6.98
Common Stock Stock Option (Right to Buy) Disposition 2020-12-14 20,000 $0.00 20,000 $7.27
Common Stock Stock Option (Right to Buy) Disposition 2020-12-14 13,333 $0.00 13,333 $9.22
Common Stock Stock Option (Right to Buy) Disposition 2020-12-14 16,666 $0.00 16,666 $13.87
Common Stock Stock Option (Right to Buy) Disposition 2020-12-14 9,005 $0.00 9,005 $19.60
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2021-03-01 No 4 M Direct
0 2022-05-25 No 4 M Direct
6,667 2023-04-19 No 4 M Direct
8,334 2023-12-12 No 4 M Direct
27,017 2024-03-01 No 4 M Direct
Reported Derivative Holdings
Show Other Fields >>
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (Right to Buy) $28.33 2027-03-02 37,514 37,514 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2027-03-02 37,514 37,514 Direct
Footnotes
  1. On March 1, 2016, Dr. Weiss was granted 50,000 stock options. These options vested ratably over the first three anniversary dates of the grant date.
  2. On May 25, 2017, Dr. Weiss was granted 20,000 stock options. These options vested ratably over the first three anniversary dates of the grant date.
  3. On April 19, 2018, Dr. Weiss was granted 20,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
  4. On December 12, 2018, Dr. Weiss was granted 25,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
  5. On March 1, 2019, Dr. Weiss was granted 36,022 stock options. These options vest ratably over the first four anniversary dates of the grant date.
  6. On March 2, 2020, Dr. Weiss was granted 37,514 stock options. These options vest ratably over the first four anniversary dates of the grant date.